|Title:||Methylation of MGMT and ADAMTS14 in normal colon mucosa: Biomarkers of a field defect for cancerization preferentially targeting elder African-Americans||Authors:||Alonso, Sergio
Daz-Chico, Juan Carlos
Chernov, Andrei V.
Strongin, Alex Y.
|Keywords:||Cpg Island Hypermethylation
Gene O-6-Methylguanine-Dna Methyltransferase
Dna Mismatch Repair
Promoter Hypermethylation, et al
|Issue Date:||2015||Journal:||Oncotarget||Abstract:||Somatic hypermethylation of the O-6-methylguanine-DNA methyltransferase gene (MGMT) was previously associated with G > A transition mutations in KRAS and TP53 in colorectal cancer (CRC). We tested the association of MGMT methylation with G > A mutations in KRAS and TP53 in 261 CRCs. Sixteen cases, with and without MGMT hypermethylation, were further analyzed by exome sequencing. No significant association of MGMT methylation with G > A mutations in KRAS, TP53 or in the whole exome was found (p > 0.5 in all comparisons). The result was validated by in silico comparison with 302 CRCs from The Cancer Genome Atlas (TCGA) consortium dataset. Transcriptional silencing associated with hypermethylation and stratified into monoallelic and biallelic. We also found a significant clustering (p = 0.001) of aberrant hypermethylation of MGMT and the matrix metalloproteinase gene ADAMTS14 in normal colonic mucosa of CRC patients. This suggested the existence of an epigenetic field defect for cancerization disrupting the methylation patterns of several loci, including MGMT or ADAMTS14, that may lead to predictive biomarkers for CRC. Methylation of these loci in normal mucosa was more frequent in elder (p = 0.001) patients, and particularly in African Americans (p = 1 x 10(-5)), thus providing a possible mechanistic link between somatic epigenetic alterations and CRC racial disparities in North America.||URI:||http://hdl.handle.net/10553/47271||ISSN:||1949-2553||DOI:||10.18632/oncotarget.2852||Source:||Oncotarget[ISSN 1949-2553],v. 6 (5), p. 3420-3431|
|Appears in Collections:||Artículos|
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.